by Stacey Johnson | Nov 12, 2021
In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM. Commercializing...
by Lyla El-Fayomi | Nov 4, 2021
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month, I cover a technologically advanced...
by Lyla El-Fayomi | Oct 1, 2021
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. It seems that I say this every month, but wow....
by Stacey Johnson | Sep 24, 2021
Let’s play a game. If you could choose, what would be your superpower? Invisibility is a popular one, as are super strength, the ability to read minds, and time travel (but we know that messing with time can be dangerous). This list of the best superpowers of all time...
by Tara Fernandez | Aug 25, 2021
The last few decades have seen a dramatic leap in life expectancies across developed countries—people are living longer than ever before, and the age of the centenarian could soon be upon us. For example, in the ‘70s Canadians lived an average of 72.7 years. Today,...
by Tara Fernandez | Jul 7, 2021
In early 2021, a young boy in Barcelona was the first to receive Pfizer’s investigational gene therapy for Duchenne muscular dystrophy (DMD). This was part of a global Phase 3 human trial to test Pfizer’s lead candidate, PF-06939926, in a cohort of 99 patients with...
Comments